Prion diseases are characteristically accompanied by extensive synaptic pathology that can occur during the preclinical phase of the disease and, in animal models, correlates with the first decline of hippocampus-dependent cognitive functions. This pathology is defined by abnormally shaped synapses in which the postsynaptic membrane modifies its curvature and potentially engulfs the juxtaposed presynaptic membrane. Using the intrahippocampally injected ME7 prion model, we further detailed the structural alterations of the population of ostensibly intact synaptic compartments within the hippocampus during this period of extensive synaptic loss. A disease stage-dependent increase in the average PSD (postsynaptic density) area, the average len...
Prion diseases are fatal neurodegenerative diseases of the CNS that are associated with the accumula...
Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functio...
Hyperphosphorylation of the microtubule-associated protein tau is a significant determinant in AD (A...
Prion diseases are characteristically accompanied by extensive synaptic pathology that can occur dur...
Recent evidence indicates that neuronal degeneration begins at the level of the synapse and progress...
Early synaptic degeneration in prion disease has developed into a subject of interest, because it is...
A growing body of evidence suggests that the loss of synapses is an early and major component of a n...
Intrahippocampal injection of the murine modified scrapie (ME7) induces a model of prion disease in ...
In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzh...
Synaptopathy is an increasingly popular term used to define key features of neurodegenerative and ps...
In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzh...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functio...
Prion diseases are fatal neurodegenerative diseases of the CNS that are associated with the accumula...
Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functio...
Hyperphosphorylation of the microtubule-associated protein tau is a significant determinant in AD (A...
Prion diseases are characteristically accompanied by extensive synaptic pathology that can occur dur...
Recent evidence indicates that neuronal degeneration begins at the level of the synapse and progress...
Early synaptic degeneration in prion disease has developed into a subject of interest, because it is...
A growing body of evidence suggests that the loss of synapses is an early and major component of a n...
Intrahippocampal injection of the murine modified scrapie (ME7) induces a model of prion disease in ...
In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzh...
Synaptopathy is an increasingly popular term used to define key features of neurodegenerative and ps...
In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzh...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Prion diseases are fatal, chronic neurodegenerative diseases of mammals, characterized by amyloid de...
Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functio...
Prion diseases are fatal neurodegenerative diseases of the CNS that are associated with the accumula...
Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functio...
Hyperphosphorylation of the microtubule-associated protein tau is a significant determinant in AD (A...